Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07451431
PHASE4

Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

Sponsor: Bangladesh Medical University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if drug Mirogabalin works to treat diabetic peripheral neuropathic pain in adults. It will also learn about the safety of the drug Mirogabalin. The main questions it aims to answer are: Does drug mirogabalin reduce neuropathic pain intensity? Is the drug mirogabalin safe in patients with diabetes suffering from neuropathic pain? Does drug mirogabalin improve patients' quality of life (QoL) ( physical, mental, and social well-being)? Researchers will compare drug mirogabalin to drug pregabalin (a drug conventionally used to treat diabetic neuropathic pain) to see if drug mirogabalin works to treat, safe and improve quality of life (QoL) in diabetic neuropathic pain. Participants will: Take drug Mirogabalin or pregabalin every day for 8 weeks Visit the clinic at 1, 2, 4, 6, 8 weeks for checkups

Official title: Efficacy, Safety and Patient-Reported Outcomes of Mirogabalin in Diabetic Peripheral Neuropathic Pain

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

78

Start Date

2025-10-01

Completion Date

2027-05

Last Updated

2026-03-09

Healthy Volunteers

No

Interventions

DRUG

Mirogabalin

Mirogabalin in diabetic peripheral neuropathic pain

DRUG

Pregabalin

Pregabalin in diabetic peripheral neuropathic pain

Locations (1)

Bangladesh Medical University

Dhaka, Bangladesh